Associate Clinician Scientist
National Neuroscience Institute of SingaporeÃ¯Â»Â¿, Singapore
Dr. Zhi Dong Zhou is graduated as a medical doctor in 1991 and had 5 years of postgraduate clinical training in internal medicine in China. Subsequently he acquired my Ph.D from Chinese Academy of Science, Shanghai Branch and started me research career in Singapore on dopamine (DA) neuron degeneration in Parkinson's disease (PD). Later he joined the National Neuroscience Institute (NNI) as a member of the Singapore National PD Translational Bench to Bedside team and continue to work on DA neuron degeneration in PD. Currently, he is an Associate Clinician Scientist in charge of the Translational Therapeutics Laboratory of NNI and an Assistant Professor at Duke-NUS, NBD as well as a PI of NMRC and SHF grants.
Dr. Zhi Dong Zhou’s interests lie in identification and verification of novel key molecular targets, signaling pathways or neuro-protective agents relevant to pathogenesis and therapy of debilitating human neurodegenerative diseases, including PD, Alzheimer’s disease (AD) and multiple sclerosis